 |
 |

Hydroa VacciniformeDiagnosis and Therapy
Mark H. Goldgeier, MD;
James J. Nordlund, MD;
Anne W. Lucky, MD;
Laurence A. Sibrack, MD;
M. J. McCarthy, MD;
Joseph McGuire, MD
Arch Dermatol. 1982;118(8):588-591.
Abstract
Hydroa vacciniforme is a rare, chronic photodermatosis with onset in childhood. Multiple exposures to UV-A reproduced the symptoms and the vesicular and scarring lesions typical of the sun-induced disease in our patient. Treatment with hydroxychloroquine sulfate, but not indomethacin, reduced the photosensitivity both to sunlight and to artificial UV-A light. Serum complement levels were low while the disease was active and returned to normal after treatment of the patient with hydroxychloroquine.
(Arch Dermatol 1982;118:588-591)
Author Affiliations
From the Department of Dermatology, Veterans Administration Hospital, West Haven, Conn (Drs Goldgeier and Nordlund); and Yale University Medical Center, New Haven, Conn (Drs Lucky, Sibrack, McCarthy, and McGuire).
Footnotes
Accepted for publication Nov 19, 1981.
Reprint requests to Division of Dermatology, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642 (Dr Goldgeier).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Pathogenic link between hydroa vacciniforme and epstein-barr virus-associated hematologic disorders.
Iwatsuki et al.
Arch Dermatol 2006;142:587-595.
ABSTRACT
| FULL TEXT
Coexistence of Hydroa Vacciniforme and Malignant Lymphoma
Oono et al.
Arch Dermatol 1986;122:1306-1309.
ABSTRACT
Hydroa Vacciniforme: Diagnosis by Repetitive Ultraviolet-A Phototesting
Eramo et al.
Arch Dermatol 1986;122:1310-1313.
ABSTRACT
|